Quick Order Cart

Cat. No. ARG43885

GPR4 Knockout SK-MEL-28 Cell Line

  • Product Type:

    In Stock Cell Lines

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Skin

  • Disease:

    Malignant melanoma

The GPR4 Knockout SK-MEL-28 Cell Line is a CRISPR/Cas9-edited knockout cell line with disruption of the GPR4 gene in the human melanoma cell line SK-MEL-28. GPR4 is a proton-sensing GPCR that couples to Gs and G12/13 proteins, driving cAMP/PKA and RhoA/ROCK signaling, leading to ERK1/2 activation and inflammatory cytokine production. This knockout model is ideal for studying pH-dependent adaptation in melanoma and GPCR signaling in the acidic tumor microenvironment. Typical applications include cancer biology, pH sensing, melanoma research, and drug target validation, with assays such as phospho-ERK1/2 western blotting, cAMP measurement, migration/invasion studies, apoptosis assays, and RNA-seq for inflammatory gene expression profiling.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-MEL-28

    Age

    51 years

    Gene Name

    GPR4

    Gene Identifier

    NCBI Gene ID 2828

    Morphology

    Polygonal

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The GPR4 Knockout SK-MEL-28 Cell Line is a CRISPR/Cas9-edited knockout cell line that enables targeted disruption of the GPR4 gene in the SK-MEL-28 human cutaneous melanoma cell line. This loss-of-function knockout model provides a defined genetic background for investigating the role of proton-sensing G protein-coupled receptor (GPCR) signaling in melanoma biology, eliminating endogenous GPR4 expression to allow precise functional characterization of pH-sensing mechanisms.

The SK-MEL-28 host cell line, derived from a male patient with malignant melanoma, is an adherent human cell line widely utilized in melanoma research. It retains characteristic features of metastatic melanoma, including dysregulated proliferation, migration, and invasive capacity, making it an appropriate platform for dissecting the molecular mechanisms that drive tumor progression and for performing comparative studies alongside other melanoma models.

GPR4 functions as a proton-sensing GPCR activated by extracellular acidic pH, coupling to multiple G proteins including Gs, Gi/o, Gq/11, and G12/13. Gs-mediated activation of adenylyl cyclase increases intracellular cAMP and PKA activity, while G12/13 stimulates RhoA/ROCK signaling; both converge on ERK1/2 phosphorylation and transcriptional upregulation of inflammatory cytokines IL-6 and IL-8. Interacting factors such as ??-arrestins modulate receptor trafficking. Representative pathway components??G??s, adenylyl cyclase, PKA, ERK1/2, RhoA, and ROCK??form a signaling network that translates acidic microenvironments into cellular responses.

In the context of SK-MEL-28 melanoma cells, GPR4 serves as a critical mediator for adaptation to the acidic tumor microenvironment, a hallmark of solid tumors. Disruption of GPR4 abrogates pH-dependent cAMP production, ERK1/2 phosphorylation, and inflammatory cytokine expression, offering a robust model to assess how proton sensing contributes to melanoma cell proliferation, migration, and inflammatory phenotypes. This knockout cell line enables dissection of pH-regulated signaling pathways distinct from other acid-sensing mechanisms.

This GPR4 knockout cell line supports diverse research applications, including cancer biology, tumor microenvironment pH sensing, GPCR signaling interrogation, melanoma research, and drug target validation. Representative experimental assays include western blotting for phospho-ERK1/2, cAMP accumulation measurements, cell migration and invasion assays, pH-dependent signaling analyses, immunofluorescence for GPR4 localization, apoptosis assessment, and RNA sequencing for inflammatory gene expression profiling. These techniques facilitate detailed mechanistic studies and preclinical evaluation of pH-sensitive pathways. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)